Informations générales (source: ClinicalTrials.gov)

NCT03240666 Statut inconnu
Multicentric Clinical Trials on the Prevalence of Entamoeba Gingivalis and Its Associated Bacterial Flora in Patients With Periodontitis (Paro-Proto)
Observational
  • Parodontite
  • Parodontite chronique
Central Hospital, Nancy, France (Voir sur ClinicalTrials)
avril 2017
novembre 2022
29 juin 2024
The buccal cavity is colonized by numerous microorganisms whose the number and composition could be modified with medical background (diseases and drugs) and the level of oral hygiene of the patients. Among all microorganisms identified in the periodontium, few of them are implicated in the etiopathogenesis of periodontal pathologies. To date, four major bacteria are identified for their ability to degrade periodontal tissues. Although the periodontitis is established to be the consequence of bacterial virulence and immune dysfunction, these factors fail to explain the refractory periodontitis of some patients to etiologic treatment . Others microorganisms such as protozoans could have an impact on this disease.
 Voir le détail

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Catherine BISSON - 54000 - Nancy - France Catherine BISSON, DDS En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Adults > 18 years-old

- consulting in periodontal department of CHRU

- Patients with moderate to severe periodontitis

- At least 2 periodontal sites with PPD ≥ 5mm and one healthy site

- No scaling root planing in the last 6 months

- Patients insured under the Franch social security system


- Pregnants patients

- Patients with antibiotic therapy and/ or all medecines which could modify the buccal
microbiota in the last 6 months

- Tooth with endodontics periapical lesion

- Patients having a scaling root planing in the last 6 months

- Patients with guardianship